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Silica@zirconia@poly(malic acid) nanoparticle: a promising  
nanocarrier for theranostic applications  
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Silica@zirconia@poly(malic acid) nanocarriers of 130 nm mean diameter were designed, synthesized and characterized for 
the targeted delivery of diagnostic and therapeutic 99mTc isotope to folate-overexpressing tumors. An important 
achievement was that a multifunctional L-(−)-malic-acid-based copolymer was formed in situ at the surface of the 
inorganic cores in a single synthetic step incorporating L-(-)-malic acid, β-cyclodextrin rings, folic acid moieties, and 
polyethylene glycol chains. Morphological and in-depth structural analysis of the particles proved their core@shell 
structure. Stability experiments in aqueous media evidenced that stable suspensions can be obtained from the lyophilized 
powder in 10 mM phosphate buffer at pH 7.4. During 14-day degradation experiments, the nanoparticles were found to be 
slowly dissolving (including inorganic core) in saline and also in total cell medium. In vitro toxicity assay on hepatocytes 
showed a concentration-dependent decrease of cell viability down to 63±1% at the highest applied concentration (0.5 
mg/ml). Proof of concept experiments of technetium-99m radiolabelling and in vivo labelling stability are presented. 
Introduction 
Application of nanotechnology in the field of theranostics has 
become a promising strategy for personalized medicine1−4. 
Various multifunctional nanoparticles are synthesized for 
targeted drug delivery5,6. However those, which combine 
diagnostic and therapeutic functionalities (nanotheranostics) 
and can be used for advanced in vivo imaging techniques (e.g. 
single photon emission computed tomography coupled to 
computer tomography, SPECT/CT)7,8 are the most important. 
The biodistribution of nanotheranostics is quantitatively 
evaluated on the basis of radiation detection, which enables 
excellent evaluation and planning of dosage when the same 
nanocarrier is used for drug delivery. 
Nanocarriers used in theranostic applications are of various 
compositions: inorganic
9,10
, organic
11−13, biological
14
 as well as 
their combinations
15,16
. The main advantages of inorganic 
nanoparticles are their well-defined size and shape, longer 
shelf-life and the conservation of their integrity in biological 
medium. On the other hand the degradability has become a 
priority to avoid the accumulation of these materials in the 
body causing unknown long-term effects. Biodegradability is 
an inherent advantage of most organic and biological 
nanocarriers. 
Silica is, however, one of the exceptional biodegradable 
inorganic materials
17,18
, which has several additional 
advantages, too: it is biocompatible, its surface modification is 
relatively easy
19,20
, and further, the diameter and shape of 
nanoparticles can be easily controlled (18-1000 nm)
21,22
.  
Zirconia, though not biodegradable, is another ceramic 
material used in medical applications as implant
23−25. Few 
papers mention its use as a drug delivery nanocarrier
26
. In fact, 
pure ZrO2 colloid with uniform size and shape could only be 
obtained with a particle diameter above 200 nm
27,28
. However, 
when silica is used as a template, continuous zirconia shell may 
be deposited on its surface and particles can be obtained with 
well-controlled size
29,30
. 
We aimed at the preparation of a new complex nanocarrier for 
the targeted delivery of theranostic 
99m
Tc isotope to folate 
overexpressing tumours by combining the advantageous 
properties of silica, zirconia with those of degradable 
polymers. Our concept was to cover Stöber silica core of nearly 
100 nm diameter with zirconia (silica@zirconia), and then form 
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a new poly(ester-amide) outer shell to be able to chelate 
99m
Tc 
ions and achieve multiple functionalities (Scheme 1).  
 
Scheme 1 Schematic representation of the silica@zirconia@polymer complex 
nanocarrier. The malic acid-based poly(ester-amide) copolymer is formed in a one-step 
surface catalysed condensation of the components. 
We chose the components of the polymeric shell on the basis 
of our previous (non-published) experience. L-(−)-malic acid is 
a potentially interesting, biocompatible material, from which a 
low molecular weight homopolymer can be easily formed by 
polycondensation
31
. According to our observations malic acid 
adsorbs strongly at the zirconia surface and still participates in 
homopolymerization reaction allowing the formation of 
surface polymeric shell. Unfortunately, the homopolymer of 
malic acid (in bulk or at the surface of ZrO2) undergoes rapid 
hydrolysis in water due to the autocatalytic effect of multiple 
unreacted carboxyl groups. This is why it cannot be used as a 
drug delivery polymer in itself. A polyol was chosen, therefore, 
to be the second component of the copolymer: β-cyclodextrin 
that should increase the conversion of polymerization 
(consumption of free carboxyl groups) and serve later as host 
for the complexation of small hydrophobic drug molecules
32
.  
Further components of the polymeric shell were: diamino 
derivative of polyethylene glycol (increases circulation time in 
blood stream
33
) and folic acid (achieves active targeting of 
folate receptor expressing tumours
34,35
). According to our 
hypothesis, these amine-containing components should 
further set back the degradation of the final copolymer thanks 
to the stability of amide bonds. 
We report on the design, synthesis and physico-chemical 
characterization of the obtained complex nanocarriers (called 
thereafter CN) including stability and degradability conditions. 
Cell viability assay on hepatocyte cells and proof-of-concept 
SPECT/CT experiments are also presented. 
Experimental section 
Materials 
Ethanol (a.r., 99.98%, max. 0.02% water, Reanal), ammonia 
solution (25%, a.r., Reanal), tetraethyl-orthosilicate (TEOS, 
puriss. GC, Sigma-Aldrich), zirconium-n-butoxide solution 
(TBOZ, 80 wt% in 1-butanol, Aldrich), L-(−)-malic acid (MA, 
puriss. >99.5%, Fluka Analytical), folic acid (FA, ≥97%, Sigma-
Aldrich), N,N-dimethyl formamide (DMF, ACS-for analysis, min. 
99.8%, Carlo Erba), β-cyclodextrin (β-CD, Cyclolab), 
dipropylamine-polyethylene glycol (diaminoPEG, SUNBRIGHT 
DE-034PA MW 2000, NOF Corporation), acetonitrile (HiPerSolv 
CHROMANORM for HPLC, VWR), Na2HPO4×2H2O (Sigma), 1 N 
NaOH solution (for analysis, Carlo Erba), saline (SALSOL, 9 
mg/ml NaCl, TEVA), penicillin-streptomycin mixture (cell 
culture tested, Sigma-Aldrich), methyl ethyl ketone (MEK, 
Reanal Ltd.), total cell medium (RPMI1640, Sigma-Aldrich), 
xylazine hydrochloride (CP-Pharma) and ketamine 
hydrochloride (CP-Pharma) were used as received. TEOS and 
TBOZ were kept under argon. Silica gel impregnated instant 
thin layer chromatography paper (ITLC-SG) was obtained from 
Pall Corporation. Millipore water (18.2 MΩcm, MilliQ System) 
was used during the experiments. Poly(L-(−)-malic acid – β-CD) 
copolymer (T40) was prepared and kindly provided by J. 
Telegdi36. The white solid has a melting point of 232.6°C and a 
specific rotation value of 
 = +41,5° (C=2, water) and a 
molar weight estimated on the basis of static light scattering 
measurement: 3530 Da. (The specific rotation of L-(−)-malic 
acid is 
 = -7.66° (C=2, acetone), melting point: 109.5°C.) 
 
Preparation of complex nanocarriers 
Silica sols with 112 nm mean particle diameter were prepared 
according to the procedure of Stöber et al.21 using 10 ml of 
TEOS, 16 ml of ammonia solution and 250 ml ethanol. 
Zirconia layer was deposited on the surface of silica particles 
with the adaptation of the procedure of Kim et al.29. 50 ml of 
silica sol (10.0±0.1 mg/ml) was diluted to 350 ml with ethanol 
under argon atmosphere in a stirred three-neck flask equipped 
with a dropping funnel. 1.5 ml of TBOZ was quickly diluted 
with 50 ml of ethanol in a mixing cylinder under argon in a 
glove box, and then was added dropwise into the vigorously 
stirred silica sol (1 h) at room temperature, 
 The reaction mixture was allowed to react for one hour. Then 
360 mg of L-(−)-malic acid was added and the particles were 
separated by centrifugation at 5000 rpm for 5 min. The acid-
capped inorganic particles were redispersed in 400 ml DMF 
solvent by ultrasonication for 2 min for further use.  
Complex nanocarrier particles were prepared by dissolving 50 
mg L-(−)-malic acid, 50 mg folic acid, 700 mg T40 copolymer 
and 50 mg diaminoPEG in 200 ml DMF solution of SiO2@ZrO2 
(2.2±0.2 mg/ml particle concentration) (molar ratio of malic 
acid : folic acid : T40 copolymer : diaminoPEG = 1 : 0.3 : 0.53 : 
0.067). The reaction mixture was heated up to 110°C, and 
stirred for one hour. After cooling down, the reaction mixture 
was purified by centrifugation and washed: once with DMF, 
three times with ethanol, and finally three times with water. 
The product was freeze-dried.  
 
Characterization 
Structure and stability of complex nanocarriers. Morphological 
investigation of nanocarriers was carried out on a MORGAGNI 
268(D) (FEI, Eindhoven, Netherlands) transmission electron 
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microscope (TEM). Diluted samples were dropped and dried 
on carbon coated copper grids. The mean particle diameter 
and shell thickness analyses were performed using Olympus 
Soft Imaging Solution iTEM Software 5.0. 
The stability of phosphate buffered CN suspensions against 
high electrolyte concentrations was checked by dynamic light 
scattering (DLS) measurements in an experimental design that 
was to imitate 
99m
Tc labelling procedure. The isotope is eluted 
from the column in saline, thus phosphate buffer was chosen 
instead of PBS to avoid double saline content. DLS 
measurements were carried out on an AvidNano w130i 
instrument (30 mW diode laser emitting at 660 nm, avalanche 
photo diode detector placed at 90° (SABRe optics)). 0.5 mg/ml 
CN suspensions in 0-90 mM phosphate buffer were prepared 
and saline was added to each suspension in 0-1 volume ratio 
(resulting buffer concentrations indicated in Table S-1 in 
Electronic Supplementary Information, ESI). 
The pH dependent zeta potential values of the samples were 
determined at 20 °C with a Malvern Zetasizer Nano ZS 
(Malvern, Worcs, UK) equipped with a He-Ne laser (λ = 633 
nm) and a backscatter detector at fixed angle of 173°. 2.5 mg 
of CN was suspended in 20 ml Millipore water and 
ultrasonicated before the measurement. 20 ml of SiO2, 
SiO2@ZrO2, and SiO2@ZrO2+MA samples in ethanol were 
centrifuged and the particles were suspended in Millipore 
water. HCl and NaOH solutions were used to adjust pH values 
between 3 and 10 (JENWAY 3540 Bench Combined 
Conductivity/pH Meter). Each symbol on the ζ-pH plot stands 
for the average and error of three measurements. 
Characterization of the polymeric shell. The presence of 
functional groups was demonstrated with attenuated total 
reflectance Fourier-transform infrared (ATR-FTIR) spectroscopy 
using a BioRad FTS-60 spectrometer equipped with a DTGS 
(deuterated triglycine sulphate) detector and a single 
reflection diamond ATR accessory ('GladiATR' with 0.6×0.6 
mm2 active surface, PIKE Technologies, UK). Scans were 
performed in the wavenumber region 4000-350 cm
-1
. In 
general, 4 cm
-1
 resolution and records of 128 scans were 
applied.  
Thermogravimetry (TG) provided information about the 
polymerization conversion and the total mass of polymeric 
shell on the surface of nanoparticles. The CN powder was also 
thoroughly checked for traces of DMF solvent by coupled TG-
MS measurements. TG measurements were performed on a 
modified Perkin-Elmer TGS-2 thermobalance and a HIDEN HAL 
2/301 PIC quadrupole mass spectrometer. About 0.6 mg 
sample was placed into the platinum sample pan and heated 
at a 20°C min-1 up to 900°C in argon atmosphere. A small 
proportion of the evolved gas and vapor was introduced into 
the mass spectrometer through a glass lined metal capillary 
transfer line heated to 300°C. The quadrupole mass 
spectrometer operated at 70 eV electron energy. 
Surface-specific elemental analysis information about the 
polymeric shell was deduced from X-ray photoelectron 
spectrum (XPS). X-ray photoelectron spectra were recorded on 
a Kratos XSAM 800 spectrometer operated at fixed analyser 
transmission mode using Mg Kα1,2 (1253.6 eV) excitation. CN 
powder was fixed on a stainless steel sample holder by a 
vacuum-compatible double sided tape. Spectra were 
referenced to the energy of the C1s line of the hydrocarbon 
type carbon, present on the surface of the samples, set at 
284.2 eV binding energy (see more details in ESI). Chemical 
states of the constituent elements were determined and 
assigned by using available references
37–39
. 
Dissolution of the polymeric shell. 6.7 mg CN sample was put on 
the top of centrifugal ultrafilter (Sartorius Stedim, VIVASPIN 
500, 0.2 µm polyethersulfone, 5 µl dead-stop volume, 
prewashed with water) and 520 µl of either saline or total cell 
medium containing 5% penicillin-streptomycin was added to it. 
The filter was closed and left stirring at room temperature. On 
days 0-1-2-3-6-9-13 the samples were centrifuged at 12500 
rpm for 30 min. Permeates were frozen till analyses, and the 
particles were resuspended in 500-500 µl saline or total cell 
medium. UV-visible spectroscopy, ATR-FTIR spectroscopy and 
high-performance liquid chromatography coupled to mass 
spectrometry (HPLC-MS/MS, see details in ESI) were 
performed on saline permeates. ATR-FTIR analysis was carried 
out on total cell medium samples. The surface of CN particles 
was analysed using ATR-FTIR spectroscopy at the end of 
degradation experiment. UV-visible spectra were recorded in a 
small-volume quartz cuvette on a Hewlett-Packard 8453 
spectrophotometer.  
Cell viability assay, radiolabelling and in vivo biodistribution. 
Toxicity of CN nanoparticles was tested with CytoTox Fluor
TM
 
Cytotoxicity Assay (Promega) on 96-well plates using MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
dye and primary rat hepatocytes  (see details in ESI).  
For radiolabelling 0.5 mg of CN was suspended in 1 ml 10 mM 
Na2HPO4 phosphate buffer (pH 7.5). The sample was 
ultrasonicated for 10 min and its size distribution function was 
assessed by DLS measurement. 500 µl (680 MBq activity) of 
sterile generator-eluted pertechnetate (
99m
TcO
4-
) solution in 
saline was added to the nanocarrier suspension. The reduction 
was carried out with 37.5 μg SnCl2 (×2H2O) in 7.5 μl 0.05 M 
HCl. 
99m
Tc-pertechnetate was derived from an UltraTechnekov 
(10.75 GBq) 
99
Mo-
99m
Tc generator (Covidien Imaging Solutions, 
USA). Labelling was performed within 20 minutes at room 
temperature. Radiochemical purity of the 
99m
Tc-labelled 
nanocarrier was examined by means of thin-layer 
chromatography (TLC) (see details in ESI). 
In vivo biodistribution of CN nanoparticles was investigated on 
three rats. Adult male Fischer-344 rats weighing 150–200 g 
were used for tumour-transplanted animal experiments. 5x10
6
 
folate receptor overexpressing He/De tumour cells (rat 
epithelial liver carcinoma) in 150 µl saline were injected 
subcutaneously into the left thighs. The animals received 
humane care complying with the criteria outlined in the 
"Guidelines for the welfare and use of animals in cancer 
research”
40
 (see further in ESI). 
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For SPECT/CT investigations, a 300 µl volume (122 MBq of 
activity/100 µg CN) of sterile radiolabelled CN suspension was 
administered into the tail vein of animals 1 hour post-labelling. 
Animals were anesthetized by administering a combination of 
xylazine and ketamine hydrochloride by the intraperitoneal 
route before the CN injection
8
. 30 minutes, 3 hours and 20 
hours post injection whole-body fusion images were taken 
from the experimental animals using an AnyScan SPECT/CT 
hybrid scanner camera (Mediso Ltd., Hungary). Fused scans 
were processed using Interview Software (Mediso Ltd., 
Hungary). Region of interest (ROI) calculations were performed 
by outlining the borders of selected organs or tracts. Injected 
dose (ID)/whole organ values were estimated from the 
resulted ROI values. 
Results and discussion 
Structure and colloid stability of complex nanocarriers 
The diameter of silica core was chosen to be around 100 nm to 
benefit from enhanced permeation and retention effect 
(EPR)
41
. The TEM picture of the CN powder shows nearly 
spherical particles with an average particle diameter of 112±10 
nm (values obtained from TEM image analysis on 50 particles) 
(Fig.1). TEM pictures of SiO2 and SiO2@ZrO2 particles are 
shown in Fig. S-1 in the ESI. 
 
Figure 1 TEM pictures of complex nanocarriers. 
According to these images, the polymeric shell covers the 
surface of the SiO2@ZrO2 spheres with an average thickness of 
5.0±2.3 nm (measurement of thickness performed on the TEM 
image of 8 particles at 73 positions).  
The deposition of surface layers was further confirmed by DLS 
measurements (see Fig. S-2a in ESI). The mean hydrodynamic 
diameter of silica particles in ethanol is 112 nm. This increases 
to 134 nm due to ZrO2 deposition. The lyophilized CN particles 
redispersed in phosphate buffer show an increased mean 
hydrodynamic diameter of 275 nm and also a larger 
polydispersity index. This suggests that at least some of the 
particles underwent cross-linking during the polymerization 
step. 
The changes in surface charge during synthetic procedure, as 
well, as the pH dependent surface charge conditions of the 
final product are well demonstrated by zeta potential vs. pH 
curves (Fig.2). The isoelectric point (IEP) of native silica 
particles is below pH 3 in agreement with previous results
42,43
. 
The IEP shifts to pH 7.5 after the deposition of zirconia. This 
corresponds to the value reported earlier for pure zirconia
44
. 
 
Figure 2 Zeta potential vs. pH analysis of the SiO2 sol, the core@shell SiO2@ZrO2 sol 
before and after addition of malic acid (+MA), and the complex nanocarriers (CN). The 
experimental error is within the symbol’s size except where marked. 
After addition of malic acid to SiO2@ZrO2 the surface charge 
becomes lower than -30 mV in the whole pH range showing 
the high affinity of malic acid to zirconia surface. This is what 
has been assumed in advance as ZrO2 is known to form strong 
surface interactions with citric acid, which is an analogue 
polydentate ligand
45
. The polymerization of multiple 
components resulted in a slight shift in the zeta potential-pH 
curve. This shows the maintained dominance of free carboxylic 
groups. The newly established chemical bonds and the overall 
surface structure of the particles was analysed by ATR-FTIR 
method (Fig.3).  
 
Figure 3 Fourier-transform infrared spectra of SiO2 sol (A), SiO2@ZrO2 sol (B) and 
complex nanocarriers (CN) (C). The difference spectrum of SiO2@ZrO0−SiO2 (B−A) is 
plotted in grey. 
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ATR-FTIR showed that the intensity of the vibrational bands 
characteristic to native silica surface (ν(Si-OH) absorption band 
at 950 cm
-1
 and ν(Si-O) at 798 cm
-1
) is not reduced after 
zirconia deposition
29,46
. The detailed spectral analysis revealed 
a new band around 1033 cm
-1
, related to (Si-O-Zr) asymmetric 
stretching. The broad band around 450 cm
-1
 corresponds to 
crystalline zirconia
47
 (see subtracted spectrum, grey line in 
Fig.3). The surface structure of nanoparticles is significantly 
altered after polymerization: amide bonds appear at 1651 and 
1553 cm
-1
, and distinct carbonyl absorption is recorded at 
1736 cm
-1
 (see spectrum C in Fig.3). These findings permit us 
to state that not only malic acid and T40 copolymer were 
integrated into the polymeric network through ester bonds, 
but amine-containing components have also been covalently 
linked in through amide bonds. The lack of signal at 73 m/z in 
TG-coupled mass spectrum confirmed the complete removal 
of DMF solvent from the CN powder. 
 
Colloid stability. Preliminary stabilization experiments showed 
that despite the highly negatively charged particle surface in 
the pH range 3-11, CN particles could only be effectively 
suspended at neutral or basic pH. This apparent discrepancy 
can be understood if we consider the pKa values of malic acid 
(pKa1 = 3.40, pKa2 = 5.20
48). At the intrinsic pH of the CN 
particle suspension (3.2), surface carboxylic groups are mainly 
protonated which can lead to the formation of numerous 
intraparticular and interparticular H-bonds. This hypotheses is 
supported by the findings of Wohlfahrt who performed 
quantum chemical calculations for the modelling of H-bonding 
ability between carboxylic side chains in proteins, and stated 
that for repulsion between proteins pH>7 is necessary49. 
Size distribution functions obtained from DLS measurements 
evidenced that 10 mM phosphate buffer is appropriate for 
stabilizing the 0.5 mg/ml suspension of CN particles up to 77 
mM NaCl concentration (see details in Figs.S-2b-d in ESI).  
 
Figure 4 DLS size distribution functions of 0.5 mg/ml CN suspension in 10 mM 
phosphate buffer before (solid line; Z-ave: 275 nm PdI: 0.163) and after 99mTc labelling 
(38.5 mM saline) (dashed line; Z-ave: 274 nm. PdI: 0.111), and 9 days after labelling 
process kept at the ambient (dotted line; Z-ave: 269 nm PdI: 0.168).  
The size distribution functions of the above suspension 
recorded repeatedly before and after radiolabeling with 
99m
Tc 
show that the colloidal stability has been maintained for at 
least 9 days after labeling as intensity weighted Z-average 
particle size and polydispersity index do not change 
significantly (38.5 mM final NaCl concentration) (Fig.4). 
 
Structure and composition of the polymeric shell 
The elucidation of the copolymer structure required a more 
detailed study. We wished to prove the presence and the 
covalent binding of all the added components. Reference 
samples have been prepared for ATR-FTIR and TG 
measurements: the physical mixture of the polymeric shell 
components (M, identical molar ratio then for CN) and their 
bulk polymerization product (PM, same molar ratio than CN 
and P, heated to 110°C in DMF for 1 h, and then washed with 
ethanol). The parallel measurement of these enabled the 
identification of spectrum signals arising from the appearance 
of new bonds. 
The superposition of absorbance bands of the monomers was 
observed in the ATR-FTIR spectrum of M. The bulk 
polymerization induced several important changes (Fig.S-3 in 
ESI). First, the dominating broad band around 1023 cm-1 
belonging to O-C(H) stretching of the cyclodextrin indicates 
that an ester backbone has formed (this band was also a 
dominating band for T40 copolymer). Second, the loss of the 
separated -OH/-NH stretching bands at 3319-3542 cm-1, and 
the appearance of characteristic amide bands at 1651 cm-1 
ν(C=O) and 1575 cm-1 δ(-NH) suggest the formation of amide 
with the amino groups of folic acid and/or diaminoPEG. It is 
important to note, that when the polymerization occurs at the 
surface of zirconia shell (CN sample), the relative intensity of 
ester-amide- vs. carboxylate-bands are reversed. This indicates 
that zirconia plays a definite role in the polymerization 
reaction, probably by forming metal-carboxylate complexes on 
its surface50. 
Similar information could be obtained from the thermal 
decomposition experiments of M, PM and CN samples (Fig.S-4 
in ESI). New degradation peaks appear for PM (e.g. intensive 
peak at 340°C), than observed previously for the mixture of 
monomers51-53 or for malic acid homopolymer54. For CN 
particles the degradation peaks are further shifted towards 
higher temperatures indicating higher polymerization 
conversion. Thus, thermogravimetric results support that the 
presence of zirconia surface interferes notably in 
polymerization process. The use of zirconia as a catalyst in 
liquid phase esterification of fatty acids was reported by 
Takahashi and coworkers
55
. However, our observation is that 
the zirconia surface itself becomes covered by a covalently 
bound polymer that cannot be completely removed of it 
anymore (the zeta potential of the particles remains highly 
negative in the pH range 3-11 after multiple dialyses). 
The surface elemental composition of the CN sample was 
analysed using X-ray photoelectron spectroscopy (see raw 
spectra in Fig.S-5 in ESI). This surface sensitive technique 
mainly provides information about the top 10 nm of the 
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sample (more than half of the information coming from the 
first nm), and could hardly detect the presence of the 
SiO2@ZrO2 core (Table 1). This result supports our observation 
based on TEM pictures that the coverage of the particles with 
polymer is complete. However, there are differences between 
the experimental (derived from XPS data) and theoretical 
composition of the polymeric shell (theoretical: 53.2% C, 
45.4% O and 1.4% N). 
 
The presence of nitrogen could not be evidenced by our XPS 
measurement (the detection limit is nearly 1 at% N). We have 
considered the possibility of segregation inside the polymeric 
shell, and calculated the atomic composition of monomers 
(Table S-2 in ESI). The experimental results agree best the 
atomic composition of diaminoPEG, which might be in excess 
on the particle surface. Similar effect has been described 
previously for poly(lactic-co-glycolic acid) surfaces prepared by 
spin coating from a homogeneous solution of polyester and 
PEG chains56.  
The presence of PEG chains at the surface of CN particles may 
ensure long circulation time in blood stream, which is 
favourable for theranostic application. On the other hand, 
these results indicate that folic acid may not be available at the 
particle surface in sufficiently high amount for folate receptor 
targeting. Further biological studies will be dedicated to the 
investigation of this issue. 
 
Dissolution of the polymeric shell  
According to our preliminary experiments the homopolymer of 
L-(−)-malic acid decomposes completely during 20 min of 
ultrasonication in water, even when formed by surface 
catalysis on silica@zirconia nanoparticles. (However, a 
monolayer of malic acid remains adsorbed at the particle 
surface.) The same occurs when a copolymer is formed at the 
surface of the particles using L-(−)-malic acid and β-
cyclodextrin monomers with the addition of diamino-PEG and 
folic acid for the last 10 min of the polymerization step (Fig.S-6 
in ESI). The rapid dissolution is a disadvantage for a 
pharmaceutical carrier candidate. We overcame this problem 
by using pre-formed copolymer of L-(−)-malic acid and β-
cyclodextrin, and with the presence of amine-bearing 
components throughout all the polymerization process. These 
nanocarriers did not lose their polymer coverage during 20 
min of ultrasonication in water according to TEM investigation. 
We examined thereafter their dissolution in saline and total 
cell medium during a two-week period. 
The dissolution rate of the polymeric shell in saline was 
analysed with mass spectrometry (Fig.5).  
 
Figure 5 Fraction of released malic acid in saline (symbols) and fitted curve (line). The 
fraction of dissolved malic acid was calculated taking the last measurement point at 
10000 min for 100%. 
The experimental points were fitted with the following 
equation: 


	 
 1   
where Q and Q0 are the quantity of released malic acid till a 
given time point and till the 14
th
 day of experiment, 
respectively, A is a constant, k is the dissolution rate, whose 
reciprocal is τ, the time constant. Malic acid release can be 
described with a time constant of 4.3 ± 0.4 day at 25°C under 
the given parameters (k = 0.232 ± 0.02 day
-1
,
 
τ1/2 = 2.98 ± 0.3 
day). Thus, half of the polymeric shell dissolves within three 
days, if the particles are daily put into fresh saline. 
Permeates in saline were further analysed by UV-visible 
spectroscopy (Fig.6a). The absorption curves show three main 
peaks at 210-219 nm, 239 nm and between 271-298 nm. The 
absorption band of malic acid (and that of T40) is near 210 nm 
(Fig.6b). It appears as a shoulder of the peak at 219 nm in the 
spectra of permeates. Folic acid absorbs light at 219 nm and at 
276 nm (depending slightly on pH
57
). β-CD has a weak 
absorption band near 240 nm, but it has two more absorption 
regions under 210 nm and between 300-320 nm. The relative 
intensity of these peaks in permeate spectra is varying in time 
confirming compositional changes during the dissolution. It is 
to note, that the most intensive absorption peak in all 
permeates observed at 239 nm cannot be assigned to any of 
the polymeric shell components. We thereafter examined the 
absorption bands of amide bonds and C=C double bonds, but 
they proved to be at lower wavelength. Finally, we prepared a 
mixture of an aqueous suspension of crystalline ZrO2 powder 
(obtained by the method of Zhou et al.
58
) with malic acid 
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solution and a second mixture with folic acid solution (Fig.6b). 
We observed the appearance of a new absorption band in the 
ZrO2+FA mixture at 239 nm, but not in ZrO2+MA. In fact, folic 
acid is known to form metal ion complexes
57,59
, but this is the 
first proof of the formation of zirconium-folate complex.  
 
Figure 6 UV-visible spectra of (a) permeates obtained from dissolution of CN particles 
in physiological salt solution and (b) day 1 dissolution sample compared to those of 
polymeric shell components and suspensions of crystalline ZrO2 powder in the 
presence of dissolved malic acid (MA) or folic acid (FA). 
As the maximal intensity of the absorbance band observed at 
239 nm is on the first day of dissolution, we assume that an 
amount of folic acid adsorbs directly to the surface of zirconia 
through carboxylic functional groups. The quick dissolution of 
these complexes suggests that the primary amine of these 
folates does not react in the polymerization reaction. 
We further analysed the FTIR spectra of CN particles at the end 
of the above 14-days-period dissolution in saline and also that 
of the sample stirred in total cell medium (Fig.S-7 in ESI). We 
not only observed the notable change in polymeric bands 
(quality and quantity) in both media, but also the partial 
dissolution of silica and zirconia. The dissolution of silica has 
been reported earlier in the literature
17,18
. On the other hand, 
the biodegradation of zirconia resulting probably from folate 
complex formation has not yet been mentioned in the 
literature. The FTIR absorption bands of the CN polyester shell 
mainly disappeared from the spectrum and there remained 
the bands of polyamide (1647 cm
-1
 and 1553 cm
-1
). The 
dissolution of silica is more pronounced in NaCl solution then 
in total cell medium. This difference is probably due to pH 
discrepancy between the two media (5.7 for saline and 7.8 for 
total cell medium). 
The results of dissolution tests suggest that silica@zirconia 
cores would not remain for long time in the living organism but 
would dissolve completely within a few months. 
 
Cell viability, radiolabeling and in vivo biodistribution  
MTT assay was used to establish the cytotoxicity of CN 
nanoparticles applying primary rat hepatocytes. Cells were 
treated for 24 h with the indicated concentration of CN, and 
then the particles were washed out. Cell viability was assessed 
following the 24 h exposure (24 h) and 24 h later (48 h), in 
order to study the longer term effect of CN. (In the second 24 
h term the cells were incubated without CN). Two-sample t-
test performed on resulting data showed a concentration 
dependent decrease of cell viability (Fig.7).  
 
Figure 7 Cell viability assay carried out on hepatocyte cells for 24 h exposure and two 
incubation times and CN concentrations between 10-500 µg/ml.  
The highest 0.5 mg/ml CN nanoparticle concentration reduced 
the viability to 63 ± 1 % and 43 ± 1 % of the control measured 
just after the exposure and at 48 h, respectively. Although NPs 
were washed out after 24 h exposure, the viability further 
decreased, which suggests that the NPs were retained in the 
hepatocytes, and/or initiated longer processes which lead to 
cell death.  
The radiolabelling efficiency was determined 30 minutes, 3 
hours and 20 hours postlabelling on the basis of TLC 
chromatograms (see chromatograms in Fig.S-8 in ESI). The 
radiolabelled products showed high degree (above 99%) and 
durable labelling efficiency during the entire in vitro follow-up 
study. We assume that the poly(ester-amide) backbone of the 
Page 8 of 10Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
25
 M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
TY
 O
F 
N
EB
RA
SK
A
 o
n 
26
/0
5/
20
16
 0
1:
51
:5
1.
 
View Article Online
DOI: 10.1039/C6TB01102K
ARTICLE Journal Name 
8 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
polymeric shell with numerous pendant carboxyl groups acts 
as a polydentate chelator.  
The in vivo biodistribution of the radiolabelled nanocarriers 
showed good correlation with products described earlier with 
similar particle size distribution
60
. Particles were quickly 
accumulated in the organs of the reticuloendothelial system 
(RES) (e.g. liver, spleen, bone marrow), and a smaller 
proportion of the radioactivity immediately started to wash-
out through the urinary tract (kidneys, urinary bladder, urine). 
Clinical side effects in experimental animals were not recorded 
during the examinations. Out of the total injected activity, an 
average 48.4 % was accumulated in the liver (nearly 50 µg) and 
9.0 % in the tumour (9 µg) in the first 30 minutes (Fig.8).  
 
Figure 8 Photograph and overlaid SPECT/CT image of a He/De tumour transplanted 
Fischer rat 3 hours after 99mTc-labelled nanocarrier injection.  
Organ activities demonstrated the slow elimination of 
nanocarrier. 8 hours post-injection almost 70% of the total 
injected activity was traceable by whole body ROI analysis. 
However, a retained blood-background could be observed 
which could be related to a relative long circulation time. 
Besides, a negligible uptake was detected in the thyroids, 
salivary gland, stomach mucosa and lungs, indicating that in 
vivo radiolabelling efficiency and particle diameters of the 
labelled nanocarriers were practically constant after i.v. 
application: particle aggregation did not occur. The obtained 
values of the organ activity uptakes are presented in Fig.S-9 in 
ESI. These findings confirm the suitability of CN sample for 
SPECT/CT application. CN particles were further applied for the 
diagnosis of folate receptor overexpressing tumours in 
spontaneously diseased veterinary patients (dog and cats). 
They have shown fair accumulation in oral carcinomas
60
. 
Conclusions 
In this paper a novel, complex structure nanocarrier has been 
proposed with the prospect of theranostic application. The 
significance of this new nanocarrier lies in its versatility: the 
easy size tuning by means of the diameter of the silica core, 
and the one-step synthesis of the multifunctional polymeric 
shell surface-catalyzed by ZrO2 coating, which allows the 
incorporation of any stable compounds bearing –OH, -COOH or 
-NH3 functionality. The chelating property of the poly(ester-
amide) backbone of the shell has allowed the efficient and 
stable radiolabelling with 
99m
Tc, but we wish to demonstrate a 
more general chelating property in the future by conducting 
labelling experiments with other isotopes of shorter half-life. 
The present study did not give evidence of the presence of 
folic acid at the surface of complex nanocarriers. We, 
therefore, will proceed to the elucidation of this issue and 
carry out in vitro and in vivo biological experiments to observe 
folic acid targeting in a future study. We also aim to carry on 
characterization of hepatotoxic potential of NPs in vitro, and 
then to confirm the in vitro results in vivo.  
CN particles and analogues with porous structure will further 
be applied for the encapsulation and release of small 
hydrophobic drugs. Such molecules are prone to form 
inclusion complexes with inbuilt β-cyclodextrin, hence, 
chemotherapy could be realized by the same pharmaceutical 
carrier as diagnosis and radiotherapy.  
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